Idaho Senate · 2025 Session
H 136: 340B drug pricing program reporting
Third Reading · March 20, 2025 · Yeas 32, nays 3 · Party-line vote
How each party voted
Senate President Pro Tempore Kelly Anthon voted yea.
Bill
- Bill
- H 136
- Motion
- Third Reading
- Date
- March 20, 2025
- Session
- 2025 Session
- Yeas–nays
- Yeas 32, nays 3
- Result
- Passed, as the official record marks it
Acting Senator Lisa Bearg voted yes in Ali Rabe's place (Idaho Code 67-412 lets a legislator on leave designate a substitute). The official tally counts that vote. The legislator on leave is listed as absent and excused.
The Journal with the roll call (PDF) ↗
The bill's page on the Legislature's site ↗
The chamber on this vote
Seats are today's members, liberal to conservative; members who have left aren't shown.
← Most liberalThe aisleMost conservative →
How each member voted
Yea (31)
- Ben Adams R-12
- Kelly Anthon R-27
- Treg Bernt R-21
- Carl Bjerke R-5
- Camille Blaylock R-11
- Van Burtenshaw R-31
- Cindy Carlson R-7
- Kevin Cook R-32
- Lori Den Hartog R-22
- Dan Foreman R-6
- Codi Galloway R-15
- Scott Grow R-14
- Jim Guthrie R-28
- Mark Harris R-35
- Phil Hart R-2
- Josh Keyser R-20
- Josh Kohl R-25
- Todd Lakey R-23
- Brian Lenney R-13
- Dave Lent R-33
- Tammy Nichols R-10
- Doug Okuniewicz R-3
- Doug Ricks R-34
- Brandon Shippy R-9
- Ron Taylor D-26
- Ben Toews R-4
- Julie VanOrden R-30
- Janie Ward-Engelking D-18
- Jim Woodward R-1
- Christy Zito R-8
- Glenneda Zuiderveld R-24
Nay (3)
- James Ruchti D-29
- Carrie Semmelroth D-17
- Melissa Wintrow D-19
Absent and excused (1)
- Ali Rabe D-16